Back

covid-19

Category

[Press Information] Orphan designation by the European Medicines Agency for LIS1, the transplant induction therapy from XENOTHERA

July 11th, 2022. # Download our press information (english version) # Télécharger...

Read More

[Press Alert] XENOTHERA announces the efficacy of its XAV-19 antibody against the BQ.1.1variant.

December 19, 2022. # Download our press alert (english version) # Télécharger...

Read More

[Newsletter] XENONEWS

November 2022. >> Official XENOTHERA’s newsletter /Lettre d’information officielle de XENOTHERA <<...

Read More

[Press Information] Orphan designation by the European Medicines Agency for LIS1, the transplant induction therapy from XENOTHERA

July 11th, 2022. # Download our press information (english version) # Télécharger...

Read More

[Newsletter] XENONEWS

June 2022. >> Official XENOTHERA’s newsletter /Lettre d’information officielle de XENOTHERA <<...

Read More

[Press Information] XENOTHERA presents LIS1 results at the American Transplant Congress (ATC) in Boston

May 2022. # Download our press information (english version) # Télécharger notre...

Read More

[Press Alert] Safety and efficacy results of LIS1

June 2022. # Download our press information (english version) # Télécharger notre...

Read More

[Press information] XENOTHERA announces the continuation of development of its anti-SARS-CoV-2 antibody.

January 2022. # Download our press information (english version) # Télécharger notre...

Read More

[Newsletter] XENONEWS

February 2022. >> Official XENOTHERA’s newsletter /Lettre d’information officielle de XENOTHERA <<...

Read More

[Newsletter] XENONEWS

December 2021. >> Official XENOTHERA’s newsletter /Lettre d’information officielle de XENOTHERA <<...

Read More

[Newsletter] XENONEWS

May 2021 >> Official XENOTHERA newsletter /Lettre d’information officielle de XENOTHERA <<...

Read More

[Press Alert] Omicron Variant : positive results for XENOTHERA's XAV-19 antibody

December 2021. # Download our press information (english version) # Télécharger notre...

Read More

[Infography/Infographie] Covid19

# 5 KEY POINTS TO KNOW ABOUT ANTIBODIES # Available here #...

Read More

[Press Alert] XENOTHERA, Nantes University Hospital and the University of Nantes announce the signature of a consortium agreement within the framework of PSPC-COVID.

July 15, 2020. # Download our press release (english version) # Télécharger...

Read More

[Newsletter - 8] NEWS/INFOS

July 17,2020. >> Official news bulletin for XAV19/Bulletin officiel du XAV19 <<...

Read More

[Newsletter - 7] NEWS/INFOS

June 26, 2020. >> Official news bulletin for XAV19/Bulletin officiel du XAV19...

Read More

[Alerte actualité] Financement XENOTHERA

15 Juin 2020. Download the press release /Télécharger le communiqué

Read More

[Newsletter-5] NEWS/INFOS

May 29, 2020. >> Official news bulletin for XAV19/Bulletin officiel du XAV19...

Read More

In the News/ A la une

Pays de la Loire (ma région) –Interview vidéo d’Odile Duvaux – Coronavirus...

Read More

[Newsletter -4] NEWS/INFOS

May 22, 2020. >> Official news bulletin for XAV19/Bulletin officiel du XAV19...

Read More

[Newsletter -3] NEWS/INFOS

May 15, 2020. >> Official news bulletin for XAV19/Bulletin officiel du XAV19...

Read More

[Newsletter -2] NEWS /INFOS

May 8, 2020. >> Official news bulletin for XAV19/Bulletin officiel du XAV19...

Read More

[Alerte actualité] Anticorps XAV19

30 avril 2020 Download the press release / Télécharger le communiqué

Read More

[Newsletter -1] NEWS / INFOS

May 1st, 2020. >> Official news bulletin for XAV19/Bulletin officiel du XAV19...

Read More

XENOTHERA

21 rue La Nouë de Fer, 44200 Nantes, France

contact@xenothera.com

Media : xenothera@akkanto.fr
Linkedin-in